Causal Inference Approaches to Estimating the Effect of Ibrutinib Dose Modifications on Progression-Free Survival in Chronic Lymphocytic Leukemia

Citation:

Dang V, Muluneh B, Chen K, et al. Clin Pharmacol Ther. 2026 Aug 6:10.1002/cpt.70436. Epub ahead of print. PMID: 42563230; PMCID: PMC13447794.